JP2023533970A5 - - Google Patents

Info

Publication number
JP2023533970A5
JP2023533970A5 JP2023501081A JP2023501081A JP2023533970A5 JP 2023533970 A5 JP2023533970 A5 JP 2023533970A5 JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023533970 A5 JP2023533970 A5 JP 2023533970A5
Authority
JP
Japan
Prior art keywords
target
detection
item
biomarker
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023501081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533970A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040971 external-priority patent/WO2022011197A1/en
Publication of JP2023533970A publication Critical patent/JP2023533970A/ja
Publication of JP2023533970A5 publication Critical patent/JP2023533970A5/ja
Pending legal-status Critical Current

Links

JP2023501081A 2020-07-08 2021-07-08 肺癌を検出するための組成物及び方法 Pending JP2023533970A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063049538P 2020-07-08 2020-07-08
US63/049,538 2020-07-08
PCT/US2021/040971 WO2022011197A1 (en) 2020-07-08 2021-07-08 Compositions and methods for detection of lung cancer

Publications (2)

Publication Number Publication Date
JP2023533970A JP2023533970A (ja) 2023-08-07
JP2023533970A5 true JP2023533970A5 (cg-RX-API-DMAC7.html) 2024-07-17

Family

ID=79552705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023501081A Pending JP2023533970A (ja) 2020-07-08 2021-07-08 肺癌を検出するための組成物及び方法

Country Status (8)

Country Link
US (1) US20240011993A1 (cg-RX-API-DMAC7.html)
EP (1) EP4179106A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023533970A (cg-RX-API-DMAC7.html)
KR (1) KR20230044429A (cg-RX-API-DMAC7.html)
CN (1) CN116113708A (cg-RX-API-DMAC7.html)
AU (1) AU2021305652A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188377A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022011197A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3793715A2 (en) 2018-05-17 2021-03-24 Meso Scale Technologies, LLC Methods for isolating surface marker displaying agents
US12631624B2 (en) 2018-10-23 2026-05-19 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
EP4460697A4 (en) * 2022-01-07 2026-06-24 Mercy Bioanalytics Inc COMPOSITIONS AND METHODS FOR THE DETECTION OF LUNG CANCER
CN114875144B (zh) * 2022-04-02 2026-04-17 及智(苏州)医学技术有限公司 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
WO2023212315A2 (en) * 2022-04-29 2023-11-02 Meso Scale Technologies, Llc. Methods for detecting and isolating extracellular vesicles
US20240309453A1 (en) * 2023-03-13 2024-09-19 Northwestern University Diagnosis of acute and chronic lung diseases by quantifying spink1 level
CN116855605B (zh) * 2023-06-13 2024-06-25 中国医学科学院北京协和医院 Aoc1作为区分卵巢透明细胞癌和高级别浆液性癌的标志物的应用
CN116593693B (zh) * 2023-07-11 2023-09-19 四川大学华西医院 一种磁性适配体探针、其制备方法和应用及迁移体富集方法
CN117741153A (zh) * 2023-11-07 2024-03-22 南京联笃生物科技有限公司 一种用于多癌种早期筛查、诊断和/或监测的生物标志物及应用
KR102752505B1 (ko) * 2024-04-23 2025-01-16 주식회사 이롬 다중오믹스 기반 폐암 진단용 바이오 마커 패널 및 이를 이용한 폐암 진단방법
CN118460477B (zh) * 2024-07-09 2024-11-05 苏州唯思尔康科技有限公司 一种特别适于内载有效货物的外泌体支架蛋白及其应用
CN119798401B (zh) * 2024-12-30 2025-10-10 常州因普迈生物科技有限公司 基于pdzk1ip1蛋白的多肽、抗体及其应用
CN120102887B (zh) * 2025-05-10 2025-07-25 浙江格物致知生物科技有限公司 一种检测肺癌的联检产品及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350320A4 (en) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
AU2011223789A1 (en) * 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
AU2013340414B2 (en) * 2012-10-23 2019-05-02 Caris Science, Inc. Aptamers and uses thereof
AU2013361323B2 (en) * 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
EP3268476B1 (en) * 2015-03-09 2025-07-16 Caris Science, Inc. Oligonucleotide probes and uses thereof
GB201511546D0 (en) * 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
GB201518655D0 (en) * 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
BR112018068461A2 (pt) * 2016-03-15 2019-01-22 Mersana Therapeutics Inc conjugado, composição farmacêutica, métodos para preparação de um conjugado e para alívio de um sintoma de um câncer.
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法
EP3740567A4 (en) * 2018-01-18 2022-03-09 Nanosomix Inc. DETECTION OF EXOSOMES AND EXOSOMAL BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS
CN108148912B (zh) * 2018-03-08 2021-10-08 四川大学 肿瘤的生物标志物、应用和肿瘤检测试剂盒
CN110954703A (zh) * 2019-12-27 2020-04-03 杭州迪相实业有限公司 一种同时检测外泌体内蛋白和rna、外泌体膜蛋白的方法

Similar Documents

Publication Publication Date Title
JP2022521781A5 (cg-RX-API-DMAC7.html)
JP7344973B2 (ja) 標的実体を検出するためのシステム、組成物、及び方法
Dai et al. Recent advances on electrochemical biosensing strategies toward universal point‐of‐care systems
Mohan et al. Profiling of circulating free DNA using targeted and genome-wide sequencing in patients with SCLC
Wu et al. DNA methylation–based classifier for accurate molecular diagnosis of bone sarcomas
JP2023510911A5 (cg-RX-API-DMAC7.html)
JP2023533970A (ja) 肺癌を検出するための組成物及び方法
JP2025504786A5 (cg-RX-API-DMAC7.html)
Rimsza et al. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues
Zhang et al. Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC
Sypabekova et al. An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection
EP3940086A1 (en) Kit for early screening of liver cell cancer and preparation method and use thereof
Pu et al. Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
WO2023004079A2 (en) Compositions and methods for detection of liver cancer
WO2023133299A1 (en) Compositions and methods for detection of lung cancer
JP2024529386A5 (cg-RX-API-DMAC7.html)
WO2017223186A1 (en) Exosome-guided treatment of cancer
Guo et al. CRISPR-AD: Combinational Detection of Blood Protein and miRNA with Digital CRISPR-Based Assay Enable to Improve the Diagnostic Performance of Alzheimer’s Disease
Piantadosi et al. Double-stranded RNA immunohistochemistry as a screening tool for viral encephalitis
CN113667757A (zh) 用于前列腺癌早期筛查的生物标志物组合、试剂盒及应用
Lee et al. A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma
US20240369560A1 (en) Compositions and methods for detection of pancreatic cancer
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
CN119339805A (zh) 用于预测对免疫治疗的响应的生物标志物及其应用